2023 Record Global Dengue Surge
2023 saw the highest global dengue case counts in recorded history — over 6 million reported cases across 80+ countries, driven by El Niño conditions and expanding Aedes ranges.
2023 Summary
| Metric | Data |
| Global reported cases (2023) | >6.5 million (record) |
| Global deaths | >7,000 |
| Countries reporting | 80+ |
| Peru 2023 | >300,000 (national record) |
| Bangladesh 2023 | 321,179 cases, 1,705 deaths (national record) |
| Americas 2023 | >4.5 million (PAHO region record) |
| Climate driver | El Niño 2023 (one of strongest on record) |
Why 2023 Was a Record Year
Multiple factors converged to produce 2023's unprecedented dengue burden. El Niño conditions — one of the strongest El Niño events on record — drove elevated temperatures and altered precipitation patterns across the tropics. In normally dry coastal Peru, El Niño brought unusual rainfall, creating Aedes breeding sites in regions with no prior dengue immunity. In Southeast Asia and South Asia, elevated temperatures extended Aedes breeding seasons and accelerated viral replication within mosquitoes (shorter extrinsic incubation period). In Brazil, which recorded over 4 million cases in the Americas alone, expanding urbanization, accumulated non-immune cohorts, and DENV-3 re-emergence after years of low circulation drove a massive surge.
Globally, the dengue burden is estimated to be 10–50× higher than reported figures due to subclinical infection and underreporting — suggesting true 2023 cases may have been 100+ million. The 2023 surge accelerated momentum for dengue vaccination programs: Brazil introduced Qdenga (TAK-003) into its national immunization program in 2024, and several other countries expanded vaccination access.
The Expanding Dengue Map
2023 also saw dengue reported in new geographic areas outside its traditional tropical range. Local dengue transmission was confirmed in parts of southern Europe (Italy, France, Spain) in 2023 — in Aedes albopictus (tiger mosquito) territory rather than Aedes aegypti. This northward expansion, driven by climate change warming temperate regions and spreading invasive mosquito species, raises concern about dengue's footprint expanding permanently into previously unaffected regions.
Sources: WHO Global Dengue 2023 situation; PAHO Americas dengue 2023; Bangladesh IEDCR dengue data; Peru MINSA dengue; Lancet (Reiner et al. dengue climate change projections).
Related: Dengue overview · Brazil dengue · Peru dengue · Bangladesh dengue
Country-by-Country Impact in 2023
The 2023 dengue surge hit multiple regions simultaneously, breaking national records on nearly every continent where dengue is endemic. In Latin America, the PAHO region recorded over 4.5 million cases — shattering all prior regional records. Brazil alone surpassed 3 million reported cases, driven by DENV-3 re-emergence after years of DENV-1/2 dominance; DENV-3 found a large non-immune population that had never encountered it. Peru declared a national health emergency after surpassing 300,000 cases — unprecedented for a country whose arid Pacific coast had historically low dengue burden, transformed by El Niño flooding that created breeding sites in normally dry zones. Bangladesh set its own tragic record: 321,179 reported cases and 1,705 deaths, with Dhaka hospitals overwhelmed in August 2023 at over 2,000 cases per day. Pakistan, Thailand, Vietnam, and the Philippines all recorded above-average seasons. The cumulative picture was a synchronized global surge driven by compounding ecological and immunological factors.
Qdenga Vaccine and the 2023 Catalyst
The 2023 record surge accelerated dengue vaccine deployment globally. Brazil — the hardest-hit country — initiated a national dengue vaccination campaign in early 2024 using Qdenga (TAK-003), targeting 10–14 year olds in the highest-burden municipalities. Qdenga, a live-attenuated tetravalent dengue vaccine, showed 61% overall efficacy against dengue infection and 84% efficacy against severe dengue in the phase 3 TIDES trial. Unlike Dengvaxia (Sanofi), Qdenga can be given regardless of prior dengue serostatus — removing the screening requirement that limited Dengvaxia deployment and raised safety concerns in seronegative individuals. The 2023 emergency highlighted an urgent gap: at the time of the surge, vaccine supply was extremely limited worldwide, and most affected countries relied entirely on vector control and clinical management with no immunological defense in their populations.
Climate Change and Dengue's Expanding Future
2023 provided a vivid preview of dengue in a warming world. Climate projections published in Nature Microbiology and updated by the Lancet Countdown suggest dengue's geographic range will expand to cover an additional 2 billion people by 2080 under high-emissions scenarios, including subtropical regions of North America, southern Europe, and parts of central Asia currently outside Aedes aegypti range. The 2023 European cases — confirmed local dengue transmission in Italy, France, and Spain — were not isolated anomalies but a trend accelerating with each decade. Aedes albopictus, the tiger mosquito, is now established across much of southern Europe and can transmit dengue, Zika, and chikungunya. Without aggressive vector control investment, expanded vaccination, and meaningful climate mitigation, dengue's status as the world's most rapidly spreading vector-borne disease will only become more consequential.